Drugs / Esp
last change Dec 2015 re-read 3 minutes ago

Esp

Protein / enzyme biologic

Developed for
chronic ulcer of skin
Investigated by
University of British Columbia

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01646502 Jul 2014 → Dec 2015 chronic ulcer of skin, venous insufficiency University of British Columbia Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Esp ClinicalTrials.gov intervention name — accepted as the source's own label NCT01646502 ↗
Modality Protein / enzyme biologic “purified Esp protein” NCT01646502 ↗
Route Topical “impregnate wound dressings with this protein” NCT01646502 ↗